# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA929821 | B | Inhibition of human cPLA2-alpha assessed as cleavage of 7-hydroxycoumarinyl-gamma-linolenate | Homo sapiens | 27 | ALA1141604 | assay format | Scientific Literature | |
2. | ALA929822 | B | Inhibition of cPLA2-alpha in Sprague-Dawley rat whole blood assay in presence of A23187 | Rattus norvegicus | 28 | ALA1141604 | tissue-based format | Scientific Literature | |
3. | ALA929823 | A | Clearance in Sprague-Dawley rat at 2 mg/kg, iv | Rattus norvegicus | 25 | ALA1141604 | organism-based format | Scientific Literature | |
4. | ALA929824 | A | Oral bioavailability in Sprague-Dawley rat at 25 mg/kg administered through MC/TW formulation | Rattus norvegicus | 23 | ALA1141604 | organism-based format | Scientific Literature | |
5. | ALA930879 | A | Oral bioavailability in Sprague-Dawley rat at 25 mg/kg administered through Phosal formulation | Rattus norvegicus | 3 | ALA1141604 | organism-based format | Scientific Literature | |
6. | ALA947340 | F | Antiinflammatory activity against carrageenan-induced paw edema in Sprague-Dawley rat at 15 mg/kg, iv | Rattus norvegicus | 4 | ALA1140903 | organism-based format | Scientific Literature | |
7. | ALA947342 | B | Inhibition of human cytosolic PLA2alpha by GLU micelle assay | Homo sapiens | 65 | ALA1140903 | single protein format | Scientific Literature | |
8. | ALA947343 | F | Inhibition of A23187-induced TBX2 release in Sprague-Dawley rat whole blood | Rattus norvegicus | 65 | ALA1140903 | tissue-based format | Scientific Literature | |
9. | ALA942291 | A | Plasma concentration in carrageenan-induced paw edema Sprague-Dawley rat model at 10 mg/kg, iv | Rattus norvegicus | 1 | ALA1140903 | organism-based format | Scientific Literature | |
10. | ALA999102 | A | Plasma concentration in adjuvant-induced arthritis Lewis rat model at 25 mg/kg, po after 4 hrs | Rattus norvegicus | 2 | ALA1150415 | organism-based format | Scientific Literature | |
11. | ALA999103 | B | Inhibition of cytosolic phospholipase A2alpha at 0.020 uM | 2 | ALA1150415 | assay format | Scientific Literature | ||
12. | ALA999104 | B | Inhibition of cytosolic phospholipase A2beta at 0.5 uM | 2 | ALA1150415 | single protein format | Scientific Literature | ||
13. | ALA999105 | B | Inhibition of cytosolic phospholipase A2gamma at 0.5 uM | 2 | ALA1150415 | single protein format | Scientific Literature | ||
14. | ALA999106 | B | Inhibition of cytosolic phospholipase A2alpha | 2 | ALA1150415 | assay format | Scientific Literature | ||
15. | ALA999107 | B | Inhibition of secreted phospholipase A2 at 0.5 uM | 2 | ALA1150415 | assay format | Scientific Literature | ||
16. | ALA999111 | B | Inhibition of COX2 in microsomes at 100 uM | 2 | ALA1150415 | assay format | Scientific Literature | ||
17. | ALA999113 | B | Inhibition of COX2-dependent PGE2 production in IL1B stimulated human A549 cells at 0.040 uM | Homo sapiens | 1 | ALA1150415 | cell-based format | Scientific Literature | |
18. | ALA999114 | B | Inhibition of COX1 in microsomes at 100 uM | 2 | ALA1150415 | assay format | Scientific Literature | ||
19. | ALA999115 | A | Oral bioavailability in rat | Rattus norvegicus | 2 | ALA1150415 | organism-based format | Scientific Literature | |
20. | ALA999119 | F | Inhibition of PGE2 production in carrageenan-stimulated orally dosed rat air pouch model after 6 hrs | Rattus norvegicus | 3 | ALA1150415 | organism-based format | Scientific Literature |